Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence

Tuberculosis

Volumn 88, Issue 3, 2008, Pages 221-234

  Dambuza, I ^a   Allie, N ^a   Fick, L ^a   Johnston, N ^a   Fremond, C ^b   Mitchell, J ^c   Quesniaux, V F J ^b   Ryffel, B ^b   Jacobs, M ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b CNRS   (France)

^c CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

Mycobacterium bovis BCG; Mycobacterium tuberculosis; Tumour necrosis factor

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR;

AIRBORNE INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL ACTIVATION; CELL DEATH; CHRONIC DISEASE; HOST RESISTANCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RESISTANCE; INFLAMMATORY CELL; LUNG GRANULOMA; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; CYTOKINES; DISEASE SUSCEPTIBILITY; LUNG; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; TUBERCULOMA; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 43049153009     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.08.011     Document Type: Article

References (62)

1. Lopez B., et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 133 (2003) 30-37
2. Goldfeld A.E., et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 279 (1998) 226-228
3. Bornman L., et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis 190 (2004) 1631-1641
4. Correa P.A., et al. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32 (2005) 219-224
5. Jouanguy E., et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 100 (1997) 2658-2664
6. Lichtenauer-Kaligis E.G., et al. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency. Eur J Immunol 33 (2003) 59-69
7. Flynn J.L., et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2 (1995) 561-572
8. Bean A.G., et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162 (1999) 3504-3511
9. Jacobs M., et al. Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation. Lab Invest 80 (2000) 901-914
10. Keane J., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345 (2001) 1098-1104
11. Keane J. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford) 44 (2005) 714-720
12. Locksley R.M., et al. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
13. Wajant H., et al. Tumor necrosis factor signaling. Cell Death Differ 10 (2003) 45-65
14. Grell M., et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83 (1995) 793-802
15. Hehlgans T., and Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115 (2005) 1-20
16. Kindler V., et al. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56 (1989) 731-740
17. Frankova D., and Zidek Z. IFN-gamma-induced TNF-alpha is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFN-gamma. Eur J Immunol 28 (1998) 838-843
18. Saunders B.M., et al. T-cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection. Clin Exp Immunol 137 (2004) 279-287
19. Mohan V.P., et al. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69 (2001) 1847-1855
20. Mueller C., et al. Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo. J Biol Chem 274 (1999) 38112-38118
21. Ruuls S.R., et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15 (2001) 533-543
22. Olleros M.L., et al. Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-alpha. J Immunol 168 (2002) 3394-3401
23. Fremond C., et al. Membrane TNF confers protection to acute mycobacterial infection. Respir Res 6 (2005) 136
24. Olleros M.L., et al. Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-Guerin and Mycobacterium tuberculosis infections. Am J Pathol 166 (2005) 1109-1120
25. Saunders B.M., et al. Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol 174 (2005) 4852-4859
26. Marino M.W., et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 94 (1997) 8093-8098
27. Jacobs M., et al. Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 100 (2000) 494-501
28. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 49 (1991) 380-387
29. Appelberg R., et al. Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence. Clin Exp Immunol 101 (1995) 308-313
30. Bekker L.G., et al. TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways. J Immunol 166 (2001) 6728-6734
31. MacMicking J.D., et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94 (1997) 5243-5248
32. Cooper A.M., et al. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect Immun 68 (2000) 6879-6882
33. Torres D., et al. Membrane tumor necrosis factor confers partial protection to Listeria infection. Am J Pathol 167 (2005) 1677-1687
34. Musicki K., et al. Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection. Infect Immun 74 (2006) 3180-3189
35. Dunn P.L., and North R.J. Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology. J Med Microbiol 45 (1996) 103-109
36. Emile J.F., et al. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol 181 (1997) 25-30
37. Saunders B.M., et al. Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 98 (1999) 324-328
38. Mulligan M.S., et al. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 142 (1993) 1739-1749
39. Hickey M.J., et al. Tumor necrosis factor-alpha induces leukocyte recruitment by different mechanisms in vivo and in vitro. J Immunol 158 (1997) 3391-3400
40. Roach D.R., et al. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168 (2002) 4620-4627
41. Zganiacz A., et al. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 113 (2004) 401-413
42. Georgopoulos S., et al. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 46 (1996) 86-97
43. Birkland T.P., et al. Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense. J Leukoc Biol 51 (1992) 296-299
44. Peck R., et al. Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. Cell Immunol 122 (1989) 1-10
45. Karp S.E., et al. in vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor. J Immunol 149 (1992) 2076-2081
46. Cooper A.M., et al. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med 186 (1997) 39-45
47. Wakeham J., et al. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice. J Immunol 160 (1998) 6101-6111
48. Ehlers S., et al. Lethal granuloma disintegration in mycobacteria-infected TNFRp55-/- mice is dependent on T-cells and IL-12. J Immunol 165 (2000) 483-492
49. Botha T., and Ryffel B. Reactivation of latent tuberculosis infection in TNF-deficient mice. J Immunol 171 (2003) 3110-3118
50. Feng C.G., et al. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol 174 (2005) 4185-4192
51. Gagliardi M.C., et al. Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN-dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production. J Leukoc Biol 78 (2005) 106-113
52. Cooper A.M., et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178 (1993) 2243-2247
53. Flynn J.L., et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 (1993) 2249-2254
54. Moore K.W., et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
55. North R.J. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 113 (1998) 55-58
56. Roach D.R., et al. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand J Immunol 54 (2001) 163-170
57. Turner J., et al. in vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 169 (2002) 6343-6351
58. Parfrey N.A., et al. Interferon-gamma gene expression during acute graft-versus-host disease: relationship to MHC induction and tissue injury. J Pathol 189 (1999) 99-104
59. Huang X.R., et al. Interleukin-10 inhibits macrophage-induced glomerular injury. J Am Soc Nephrol 11 (2000) 262-269
60. Watanabe Y., and Jacob C.O. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell. J Immunol 146 (1991) 899-905
61. Lewis K.N., et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 187 (2003) 117-123
62. Majlessi L., et al. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol 174 (2005) 3570-3579